Hypertonicity counteracts MCL 1 and renders BCL XL a synthetic lethal target in head and neck cancer

URN to cite this document:: urn:nbn:de:bvb:355-epub-445317
DOI to cite this document:: 10.5283/epub.44531

Ehrenschwender, Martin ; Heimer, Sina ; Knoll, Gertrud ; Neubert, Patrick ; Hammer, Karin P. ; Wagner, Stefan ; Bauer, Richard J. ; Jantsch, Jonathan

Preview

License: Creative Commons Attribution Non-commercial 4.0
PDF - Published Version
(15MB)

Date of publication of this fulltext: 26 Jan 2021 16:42

Alternative links to fulltext:DOI Publisher

This publication is part of the DEAL contract with Wiley.

Details

Preview

Indexed in

Export bibliographical data

Abstract

Head and neck squamous cell carcinoma (HNSCC) is an aggressive and difficult-to-treat cancer entity. Current therapies ultimately aim to activate the mitochondria-controlled (intrinsic) apoptosis pathway, but complex alterations in intracellular signaling cascades and the extracellular microenvironment hamper treatment response. On the one hand, proteins of the BCL-2 family set the threshold for ...